Cleveland Clinic’s Top Innovations, 2022
May 10, 2022 | Terry Sharrer
Here’s the list: “Next generation of mRNA vaccinology; PSMA-targeted therapy in prostate cancer; Inclisiran, a new treatment for the reduction of low-density lipoproteins; Once-weekly injectable dual glucose-dependent insulinotropic polypeptide, a novel drug that treats Type 2 diabetes; Brexanolone, intravenous infusion treatment to treat postpartum depression; Targeted medication for hypertrophic cardiomyopathy; Nonhormonal alternatives for menopause treatment; Implantable brain-computer interface technology for severe paralysis; Artificial intelligence for early detection of sepsis; Predictive analytics for hypertension.” MORE
Image Credit: ClevelandClinic.org